Evidence map

ReviewCancers2026

Myosteatosis: A Distinct, Early and Targetable Novel Biomarker of Cancer Prognosis.

Nagi B KumarPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41899576